Achilles
Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 201-500
Industries / Tags:
Detailed Achilles Information
Geographic Data
Address: 245 Hammersmith Road
City: London
State: england
Zip: W6 8PW
Country: GB
Financial Info
Stage:
grant
Raised Last:
$4M
Raised Total:$213M
Social
Metrics
4,740,758Website Global Rank
1,832Website Monthly Traffic
Twitter Followers
Description
Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Achilles went public on 3/30/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/30/2021
IPO Valuation:
$731M
Ticker Symbol:
ACHL
IPO Price:
$18/share
Amount Raised:
$176M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
